01 1KEKULE PHARMA LIMITED
02 1Sionc Pharmaceutical Private Limited
01 1NILUTAMIDE
02 1Nilutamide
01 2India
NDC Package Code : 53220-123
Start Marketing Date : 2016-04-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76055-0012
Start Marketing Date : 2019-12-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
55
PharmaCompass offers a list of Nilutamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Nilutamide manufacturer or Nilutamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nilutamide manufacturer or Nilutamide supplier.
A Anandron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anandron, including repackagers and relabelers. The FDA regulates Anandron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anandron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Anandron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Anandron supplier is an individual or a company that provides Anandron active pharmaceutical ingredient (API) or Anandron finished formulations upon request. The Anandron suppliers may include Anandron API manufacturers, exporters, distributors and traders.
click here to find a list of Anandron suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Anandron as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Anandron API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Anandron as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Anandron and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Anandron NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Anandron suppliers with NDC on PharmaCompass.
We have 2 companies offering Anandron
Get in contact with the supplier of your choice:
